Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.
Press releases published on October 26, 2025
Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) …
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the pricing of a best …
MapLight Therapeutics Announces Pricing of Initial Public Offering
SAN FRANCISCO and BOSTON, Oct. 26, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the …
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
VIENNA, Austria, Oct. 26, 2025 (GLOBE NEWSWIRE) -- A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with a focus on aging populations and individuals with …
New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus
FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating that its TissueCypher® Barrett’s Esophagus …
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were treated with a single dose of FT819 with less-intensive or no conditioning chemotherapy Favorable safety profile …
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
LANDSHUT, Germany, Oct. 26, 2025 (GLOBE NEWSWIRE) -- The latest release of mediCAD® 8 by mediCAD Hectec GmbH marks a new era in intelligent orthopedic and trauma planning. Combining artificial intelligence, automation, and with a completely new user …
Polpharma Group gibt Führungswechsel bekannt – Ernennung von Sebastian Szymanek zum neuen Präsidenten
AMSTERDAM, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, eines der größten Pharmaunternehmen in Mittel- und Osteuropa sowie Zentralasien, gibt einen geplanten Führungswechsel bekannt. Mit Wirkung zum 1. Januar 2026 wird Markus Sieger nach zehn …
Polpharma Group annonce un changement de direction – Sebastian Szymanek nommé nouveau président
AMSTERDAM, 26 oct. 2025 (GLOBE NEWSWIRE) -- Polpharma Group, l’un des plus grands groupes pharmaceutiques opérant en Europe centrale, orientale et en Asie centrale, annonce une transition planifiée de sa direction. À compter du 1er janvier 2026, Markus …